The present invention relates to metal/organic complexes of Formula (I), (II) (III), (IV), (V) and (VI) that are useful as catalysts for the polymerisation of carbonyl-containing or cyclic monomers. Typical polymerisation reactions are, for example, those of lactides.
The compounds of the present invention are metal/organic complexes and are complexes are alkoxides or aryloxides formed from chiral, bidentate ligands. They are particularly useful for stereoselective polymerisation of these monomers. The complexes are alkoxides or aryloxides formed from chiral bidentate ligands and single metal cations and are of the general structures below where R may be selected from the group consisting of hydrogen, hydrocarbyl or substituted hydrocarbyl and M may be any Lewis-acidic metal, for example the s-block, f-block metals or scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, yttrium, zirconium, tin or aluminium. Preferentially the metal may be an f-block metal. More preferably the metal may be from the lanthanide series, for example europium or erbium.
It is known that metal alkoxides are active ring-opening polymerisation catalysts. A number of metal alkoxides have been used in polymerisation reactions. Examples include tin, aluminium and zinc.
A widely used catalyst for the preparation of poly lactide is tin(II)octanoate [tin(II)bis(2-ethylhexanoate), Sn(Oct)2] (Chem. Rev. 104: 6147-6176 (2004)). However, the use of a tin-based catalyst may not be appropriate where the polymer is to be used in a biomedical application as tin is toxic and there may be traces of the tin catalyst in the polymer product. Also, tin(II)octanoate requires activation with an alcohol and activity of the catalyst is generally low. The structure of tin(II)octanoate is given below:
Aluminium alkoxides are less active than tin(II)octanoate (Am. Chem. Soc. 121: 4072-4073 (1999)) and there are concerns about the use of aluminium as catalyst for polymerisation of biomedical polymers as it has been linked to Alzheimer's disease. The structure of an aluminium alkoxide is given below:
Zinc alkoxides are considered to be non-toxic, however their activity is low.
The use of yttrium and rare earth metals for the catalysis of lactone polymerisation is the subject of U.S. Pat. Nos. 5,028,667 and 5,235,031 and PCT application number WO9619519. None of these documents report the use of chiral ligands to achieve stereoselective polymerisation and therefore the present invention is novel.
Commercial polylactides are synthesised from lactide monomers prepared from a single lactic acid enantiomer in order to obtain stereoregular polymers with a high degree of crystallinity. Polylactides derived from racemic lactide are amorphous with a lower glass transition temperature.
It has been reported that L-polylactide and D-polylactide form a stereocomplex with a melting temperature 50° C. greater than the homochiral polymers. Preparation of such a stereocomplex currently requires parallel ring-opening polymerisation of D-lactide and L-lactide and subsequent combination of the chiral polylactide chains. U.S. Pat. Nos. 4,800,219, 4,766,182 and 4,719,246 describe polylactide compositions with enhanced physical properties. These compositions are obtained by mixing single enantiomers of D- and L-lactide in order to obtain stereocomplex polylactide.
Despite the improved physical properties of the stereocomplex, practical applications of the stereocomplex are restricted by the requirement for separate pools of enantiopure lactide monomers to generate enantiopure polymers i.e. there is a need to devise a method for preparing stereocomplex polylactide from racemic lactide monomer (J. Am. Chem. Soc. 122: 1552-1553 (2000)). An aluminium alkoxide catalyst has been generated that permits stereoselective polymerisation, however the activity of the polymer is low and the molecular weight of the resulting polymers is not sufficient for industrial applications such as packaging (Macromolecular Chemistry and Physics 197(9): 2627-2637 (1996)).
It is therefore an object of the present invention to provide novel metal/organic complexes suitable for use as polymerisation catalysts. Another object of the present invention is to provide improved catalysts which are able to operate under more environmentally friendly conditions e.g. at lower temperatures or in more environmentally friendly solvents. It is a further object of the present invention to provide improved catalysts that are capable of rapidly polymerising a monomer. It is a further object of the present invention to provide improved catalysts with reduced toxicity. It is yet another object of the present invention to provide improved catalysts which are capable of producing higher molecular weight polymers. It is yet another object of the present invention to provide improved catalysts which are capable of producing low polymer dispersity polymers.
The present invention fulfils all or some of the above objects of the invention.
The present invention discloses new metal/organic complexes that are useful as catalysts for the polymerisation of carbonyl-containing or cyclic monomers, for example lactide. The complexes are particularly useful for stereoselective polymerisation of these monomers.
According to the first aspect of the present invention, there is provided a compound of Formula (I), (II), (III), (IV), (V) or (VI):
wherein R is independently selected at each occurrence from the group comprising: hydrogen, hydrocarbyl and substituted hydrocarbyl,
M is a Lewis-acidic metal and
X, if present, is any suitable counter ion.
In one embodiment, the complexes are alkoxides or aryloxides formed from chiral bidentate ligands and single metal cations. In an alternative embodiment, the complexes are alkoxides or aryloxides formed from chiral tridentate ligands and double metal cations. In another alternative embodiment, the complexes are alkoxides or aryloxides formed from a mixture of chiral bidentate and chiral tridentate ligands and single metal cations.
The drawings are not intended to limit the invention to any specific stereoisomer. All potential stereoisomers arising from planar, axial or centrosymmetric stereoelements are claimed herein.
In another aspect the present invention also discloses the use of these catalysts for stereoselective polymerisations of carbonyl-containing or cyclic monomers, for example lactide, glycolide, ε-caprolactone or ε-caprolactam.
The use of such stereoselective catalysts confers more precise control over the properties of a polymer and to allow more efficient polymer production. The resulting polymers have a number of applications in the biomedical industry e.g. surgery (tissue or bone repairing, sutures and controlled release drug delivery), food packaging (as a polyethylene alternative), agriculture and the engineering industry.
Inevitably trace amounts of catalyst are present in the resulting polymer and for this reason the catalysts of the present invention are particularly useful in producing polymers used in food and medical applications due to their low toxicity.
An example polymer which can be produced by a catalyst of the present invention is poly lactic acid (PLA). PLA is both biodegradable and bioassimilable. An additional environmental benefit with PLA is that the monomer, D,L-lactide is readily available by the fermentation of corn starch (a carbon neutral process). The molecular weight range of PLA is controllable between 1000 and 500000 g/mol and is dependent upon the catalyst used and conditions employed. The mechanical properties of PLA range from viscous oils and soft elastic plastics to stiff, high strength materials comparable to polyethylene.
In another aspect of the present invention, these catalysts may also be used for asymmetric Lewis-acid catalysed reactions, for example chiral Diels Alder reactions, asymmetric aldol (or aldol derivative) reactions.
In one aspect, the present invention relates to metal/organic complexes of Formula (I), (II) (III), (IV) (V) and (VI) that are useful as catalysts for the polymerisation of carbonyl-containing or cyclic monomers.
In any of the above embodiments, the substituted hydrocarbyl group may be substituted with one or more heteroatoms. Preferred heteroatoms include N, S, O, and Si.
M may be selected from s-block, p-block, d-block and f-block metals. M may be any Lewis-acidic metal, for example lithium, beryllium, sodium, magnesium, potassium, calcium, rubidium, strontium, caesium, barium, francium, radium, scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, yttrium, zirconium, tin, aluminium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, thorium, protactinium, uranium, neptunium, plutonium, americium, curium, berkelium, californium, einsteinium, fermium, mendelevium, nobelium and lawrencium.
In an embodiment, the metal is selected from magnesium, calcium, scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, yttrium, zirconium, europium, erbium, tin or aluminium. Preferentially the metal may be an f-block metal. More preferably the metal may be from the lanthanide series, for example europium or erbium. Preferentially the metal is selected from the group comprising: magnesium, calcium, titanium, zinc, yttrium, europium, erbium, ytterbium, tin or aluminium.
In an embodiment, each R group is optionally substituted where chemically possible with 1 to 3 substituents selected from the group consisting of halo, hydroxy, oxo, cyano, mercapto, nitro, (C1-C4)alkyl, and (C1-C4)haloalkyl.
In an embodiment, each R is independently selected from the group comprising:
a) (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C1-C6)alkoxy, (C1-C6)alkyl-S—, (C1-C6)alkylamino, and di[(C1-C6)alkyl]amino; wherein each of said groups may optionally be substituted where chemically possible with 1 to 3 substituents independently selected from the group consisting of halo, hydroxy, cyano, mercapto, nitro, (C1-C4)alkyl, and (C1-C4)haloalkyl; or
b) 5- to 10-membered heteroaryl containing 1 or 2 ring heteroatoms independently selected from the group consisting of N, S or O; wherein said heteroaryl ring may optionally be substituted with 1 to 3 substituents per ring independently selected from the group comprising: halo, hydroxy, cyano, mercapto, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, or
c) phenyl, naphthyl, anthracenyl, phenanthranyl, and indenyl, wherein each of the foregoing groups is optionally be substituted with 1 to 3 substituents per ring independently selected from the group comprising: halo, hydroxy, cyano, mercapto, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy.
In a preferred embodiment, each R is independently selected from the group comprising:
a) (C1-C6)alkyl, (C2-C6)alkenyl, and (C2-C6)alkynyl; or
b) 5- or 6-membered-heteroaryl containing 1 or 2 ring heteroatoms independently selected from the group consisting of N, S or O; or
c) phenyl and naphthyl.
When an individual R group is alkyl, it is preferably propyl or butyl. Most preferably it is t-butyl. When an individual R group is an aryl group, it is preferably a phenyl group which may be optionally substituted with 1 to 3 independently chosen substituents selected from halogen, CN, OH, NO2, C1-4 alkyl and C1-4 alkoxy.
In a second aspect, the invention is related to the use of the catalysts of the present invention for stereoselective polymerisations of carbonyl-containing or cyclic monomers, for example lactide, glycolide, ε-caprolactone or ε-caprolactam.
Not meaning to be bound by theory, it is thought that the mechanism for the ring opening polymerisation (ROP) of D,L-lactide follows the route illustrated in scheme 3a:
It is already known in the prior art that if one enantiomer of lactide is polymerised, e.g. D-lactide, then the resulting polylactide is the D enantiomer, D-polylactide. Likewise if L-lactide is polymerised the resulting PLA is L-polylactide. It is also known that if L-polylactide and D-polylactide are mixed and annealed, the L and D enantiomers form a more stable stereocomplex which has a melting point 50° C. higher than either L-lactide or D-lactide. The increase in melting point is believed to be due to the complementary interaction between each enantiomer. This is illustrated in scheme 3b:
If a racemic mixture of D,L-lactide is polymerised with a racemic mixture of a catalyst of the present invention, a mixture of D- and L-polylactide is produced. Annealing this mixture allows the formation of a stereocomplex.
The increased stability and higher melting point of the stereocomplex increases the number of potential uses for the polymer. For example the polymer stereocomplex will have many useful applications in engineering.
In one embodiment, the novel catalysts are prepared from chiral bidentate ligands as described herein.
One method of preparing the chiral bidentate ligand is illustrated in reaction scheme 1a:
In another embodiment, the novel catalysts are prepared from chiral tridentate ligands.
One method of preparing the chiral tridentate ligands is illustrated in the reaction scheme 1b:
Bimetallic, tridentate ligand complexes (of formula (V)) can be produced by reaction scheme 2a:
In another embodiment, the novel catalysts are prepared from both chiral bidentate and chiral tridentate ligands.
Mixed bidentate/tridentate ligand complexes (of formula (VI)) can be produced by the reaction scheme 2b:
The invention is illustrated by way of example only by the following Figures:
FIG. 7A/B: X-ray crystal structures of (A) ligand 1 and (B) catalyst 1.
FIGS. 13A/B/C: (A) 1H NMR, (B) homonuclear decoupled 1H NHR and (C) 13C NMR spectra of polymer produced using D,L-lactide and 1% catalyst 2.
FIGS. 14A/B: (A) standard 1H NMR and (B) 13C NMR spectra for polymer made using L-lactide and 1% catalyst 2.
a-e: NMR Spectral characterization of polymers.
Table 7 provides a comparison of the use of ErL13 (the catalyst presented in
Table 8 provides examples of polymerization under different reaction conditions. The reactions for catalysts of the present invention (table 8, DCM) were carried out at −18° C. which is much lower than the temperature traditional methods employing Sn(Oct)2 are carried out at. This illustrates the economic and environmental benefits of using a catalyst of the present invention e.g. greater energy efficiency. Additionally, because the reaction employing a catalyst of the present invention may be carried out in a range of solvents, (see
a) methine region of the homonuclear decoupled 1H-NMR for entry 1. Integration of the iii peak corresponds to 26.2%. 1H-NMR δ(CDCl3): 5.146, 5.161, 5.171, 5.178, 5.181, 5.185, 5.202 [ppm].
b) methine region of the homonuclear decoupled 1H-NMR for entry 2. Integration of the iii peak corresponds to 88.8%. 1H-NMR δ(CDCl3): 5.103, 5.181, 5.200 [ppm].
c) methine region of the homonuclear decoupled 1H-NMR for entry 3. Integration of the iii peak corresponds to 78.7%. 1H-NMR δ(CDCl3): 5.144, 5.160, 5.178, 5.198, 5.211, [ppm].
d) methine region of the homonuclear decoupled 1H-NMR for entry 4. Integration of the iii peak corresponds >99%. 1H-NMR δ(CDCl3): 5.151 ppm.
e) methine region of the homonuclear decoupled 1H-NMR for entry 5. Integration of the iii peak corresponds to 36.1%.
1H-NMR δ(CDCl3): 5.097, 5.126, 5.139, 5.165, 5.179, [ppm].
Specific embodiments of the present invention are illustrated in the following examples. The examples should no be interpreted as limiting to the scope of the present invention.
The synthesis of the proligand requires three steps. First a double Grignard reaction between magnesium tertiobutyl chloride and PBr3 yields tBu2PBr (Scheme 4). The compound was obtained as a yellow oil and purified by distillation under reduced pressure (10−2 mbar); pure tBu2PBr was isolated as a colourless oil, characterised by 1H and 31P NMR spectroscopy.
tBu2PBr was treated with LiAlH4, yielding tBu2PH, which was subsequently treated with nBuLi to make LiPtBu2 which was treated with 3,3-dimethyl-epoxybutane, and the resulting compound oxidised with H2O2 to give the targeted proligand HLR in a modified procedure based on that of Genov D., Kresinski R., Tebby J., J. Org. Chem., 1998, 63, 2574.
The general synthesis for HLR: R=tBu 1, R=Ph 2 is shown Scheme 5. An analogue R-HLR 1a was synthesised by a R-epoxide following the same procedure.
A THF solution of HLPh 2 was treated with nBuLi, yielding LiLPh 3 (Scheme 6).
A range of metal complexes of LR were synthesised using a variety of different metal starting materials, as shown in scheme 7. All reactions were conducted in toluene at 80° C. overnight.
All the complexes were characterised by 1H and 31P and some also by mass spectroscopy analysis and X-Ray crystallography.
Synthesis of Catalysts from MCl2/HLR
In this route, a metal dichloride salt was treated with two equivalents of the ligand in toluene at 70° C. overnight (scheme 8). It was envisaged that the elimination of HCl would provide a good driving force for the reaction.
This reaction had limited success; the treatment of MCl2 (M=Mg, Zn, Sn) with two equivalents of HLR affords [M(HLR)2(Cl)2]M=Mg (4), Zn (5), and Sn (6) respectively, in excellent yield.
Two magnesium complexes were synthesised from MgCl2 with two equivalents of HLR affords [Mg(HLR)2(Cl)2]HLR=1 (4tBu), 1a (4a) the R,R-4tBu analogue and 2 (4Ph).
Complex 4tBu was isolated in a yield of 70.1%, the 31P NMR spectrum contains two resonances (70.0 and 70.6 pm) and 1H NMR spectrum contains a broad singlet at 5.22 ppm (O—H). The mass spectrum results shows m/z (11.5%)=582.6 [4tBu-HCl] and m/z (7.1%)=546.6 [4tBu-2HCl]. After contact of 4tBu with water a new complex (scheme 9) is formed with a molecule of water coordinated to the magnesium.
The C2-symmetric chirality is confirmed by a single crystal X-ray diffraction study of 4tBu.H2O; Scheme 9 shows the molecular structure of the SS-diastereomer.
The 31P NMR spectrum of the diastereomerically pure complex 4a contains only one resonance at 69.8 ppm and the 1H NMR spectrum contains a broad resonance (OH) at 5.77 ppm.
The complex 4Ph was isolated in a yield of 75.5%. The resonance for the OH is significantly changed upon complexation from 5.22 ppm (4tBu) to 3.65 ppm (4Ph). The mass spectrometric analysis shows m/z (8.49%)=663.1 [4Ph-HCl].
Two zinc complexes were synthesised from ZnCl2 with two equivalents of HLR affords [Zn(HLR)2(Cl)2]HLR=1 (5tBu), and 2 (5Ph).
Complex 5tBu was isolated in a yield of 81.9%; the 31P NMR spectrum contains one resonance at 72.6 pm, and the 1H NMR spectrum contains a broad singlet at 4.63 ppm (OH) in, opposition at 5.22 ppm in 1H NMR for 4tBu. The mass spectrum shows m/z (10.5%)=623.0 [5tBu-HCl] and m/z (7.1%)=587.0 [5tBu-2HCl]. A single tablet grown which is not representative of the bulk shows scheme 10.
From scheme 10 and the presence of HCl, it is apparent that the formation of [Zn(HLR)2(Cl)2] is certainly favourite instead of ZnLR2 for the zinc as the magnesium.
Complex 5Ph was isolated in a yield of 85.0%; the 31P NMR spectrum contains one resonance at 41.6 pm, and the 1H NMR spectrum contains a broad singlet at 4.95 ppm (OH). The mass spectrum shows m/z (7.3%)=667.4 [5Ph-2HCl].
Two tin complexes were synthesised from SnCl2 with two equivalents of HLR affords [Sn(HLR)2(Cl)2]HLR=1 (6tBu), and 2 (6Ph). In opposition of the magnesium and zinc catalysts which were air and moisture sensitive, the both tin complexes were air and moisture stable.
Complex 6tBu was isolated in a yield of 80.7%, the 31P NMR spectrum contains one resonance at 76.1 pm, and the 1H NMR spectrum doesn't show any broad singlet for OH. In opposition with 4tBu at 5.22 ppm in the 1H NMR spectrum. Further more the two compounds were really different, 4tBu was a colourless solid while 6tBu was colourless glue but the mass spectrum shows m/z (39.1%)=677.3 [6tBu-HCl], m/z (29.8%)=640.3 [6tBu-2HCl].
Complex 6Ph was isolated in a yield of 88.5%; the 31P NMR spectrum contains one resonance at 39.7 pm, and the 1H NMR spectrum contains a broad singlet at 4.61 ppm (OH). In opposition with 6tBu which possessed any OH bond in 1H NMR. The mass spectrum shows m/z (30.3%)=721.0 [6Ph-2HCl].
Synthesis of Catalysts from MCl2/LiLR
To avoid the presence of chloride in the final complexes, salt elimination method was carried out. The ligand 2 was treated with n-BuLi to afford the lithium salt 3, which was treated with ½ an equivalent of ZnCl2 in toluene, overnight at −78° C. (scheme 11).
Complex 7Ph was isolated in a yield of 74.2%; the 31P NMR spectrum contains one resonance at 40.0 pm, and the 1H NMR doesn't contains a resonance OH, in opposition of 5Ph (4.95 ppm); the aromatic resonances were broader than in the 5Ph.
The mass spectrum shows m/z (100.0%)=610.0 [7Ph-tBu].
Synthesis of Catalysts from MN″2/HLR
To avoid the presence of chloride in the final complexes, amine elimination method was carried out. Two equivalents of ligands 1 and 2 were added to a solution of one equivalent of Ca[N(SiMe3)2]2(thf)2 in thf, overnight at −78° C. (scheme 12).
For the complex 8tBu; the 31P NMR spectrum contains one resonance at 69.4 pm, and the 1H NMR spectrum doesn't contain a resonance OH, just the resonances expected. The reaction was carried out in NMR so the yield wasn't optimised but it was possible to remove the volatile compound to afford colourless solid 8tBu.
Complex 8Ph was isolated in a yield of 37.8%, low yield due to a problem in the purification; the 31P NMR spectrum contains one resonance at 20.0 pm, and the 1H NMR doesn't contain a resonance OH, just the resonances expected.
Some NMR experiments were carried out with CaCl2/HLR to compare but they didn't get any concrete results to study due to the insoluble character of CaCl2.
Synthesis of Catalysts from MR2/HLR
To avoid the presence of chloride in the final complexes, alkyl elimination method was carried out. Two equivalents of ligands 1 and 2 were added to a solution of one equivalent of ZnEt2/toluene in toluene, overnight at 70° C. (scheme 13).
The complexes 9tBu and 9Ph were difficult to isolate and characterise, due to the low quantity of starting material (0.17 ml and 0.15 ml for ZnEt2 in the synthesis of 9tBu and 9Ph, respectively). Meanwhile, the 31P NMR spectrum contains a resonance at 68.8 ppm for 9tBu and at 52.0 ppm for 9Ph. The 1H NMR spectrum of 9Ph doesn't show any resonance for OH.
In comparison, the zinc complexes synthesised via MCl2/HLR (5) have shown in the 1H NMR spectrum a OH resonance for the both ligands.
The 31P NMR spectrum contains a higher resonance for 9Ph (52.0 ppm) than for 5Ph (41.6 ppm) or 7Ph (40.0 ppm).
After all the studies in the zinc complexes, it was choosing to concentrate the research on the method which has synthesised 7Ph. It's allowed a product without HCl 5Ph and it's safer than use diethyl zinc 9Ph.
Synthesis of Catalysts from MR3/HLR
Following previous research in our group, we are targeted C3-symmetric racemic complexes with main group element by the utilisation of trisalkyl aluminium (AlMe3 and DABAL-Me3)
Firstly, a solution of three equivalents of 1 or 2 was added to a solution of one equivalent of AlMe3/hexanes in deuterated benzene, overnight at 70° C. to afford complexes 10tBu and 10Ph respectively (scheme 14) which were difficult to isolate and characterise, due to the low quantity of starting material (0.14 ml and 0.1 ml for AlMe3. Meanwhile, the 31P NMR spectrum contains a resonance at 79.3 ppm for 10tBu and at 51.0 ppm for 10Ph.
Secondly, a solution of six equivalents of 1 or 2 was added to a solution of one equivalent of DABAL-Me3 in toluene, overnight at 70° C. to afford complexes 11tBu and 11Ph respectively (scheme 15).
The 31P NMR spectrum contains a resonance at 78.7 ppm for 11tBu and at 51.0 ppm for 11Ph which are results close to these obtain with 10tBu (79.3 ppm) and 10Ph (51.0 ppm). The 1H NMR spectra contain no extra proton resonance for the both complexes 11.
In the case of the tris-tert-butyl aluminium complexes (10tBu and 11tBu) the phosphorus resonances were the highest obtained during theses complexations.
Synthesis of Catalysts from MN″3/HLR
Treatment of Ln(N{SiMe3}2)3 (Ln=Y) with three equivalents of 1 in thf at low temperature affords LnL3R Ln=Y (12), in excellent yield, after recrystallization from pentane (scheme 16), complex 12 is colourless.
Complex 12tBu was isolated in a yield of 90.0%, the 31P NMR spectrum contains two resonances at 70.5 pm and 70.1 ppm, the composition was confirmed by microanalysis, and complex 12a (made by 1a R-HLtBu) was isolated in a yield of 86.5%, the 31P NMR spectrum contains one resonance at 68.6 ppm.
Comparison of the 1H and 31P{1H} NMR spectra of solutions of 12 and 12a show what appears to be predominantly the same compound, save for an additional, minor set of resonances in the spectra of 12, which correspond to a minor diastereomer, RRS-/SSR-YtBu, present in about 20% of the total yield. The C3-symmetric chirality is confirmed by a single crystal X-ray diffraction study of 12.
Complex 12Ph was isolated in a yield of 75.1% (yield non-optimised); the 31P NMR spectrum contains three 42.8 ppm (major), 42.3 and 42.0 ppm (minor); an additional, minor set of resonances in the 1H NMR spectrum of 12Ph, which correspond to a minor diastereomer, RRS-/SSR-12Ph, present in about 30% of the total yield
Preparation of (t-Bu)2P(O)CH2CH(t-Bu)OH, HL (Ligand)
A 1.6 M hexane solution of n-BuLi (15 ml, 25 mmol) was added dropwise to a solution of 3,3-dimethyl-epoxybutane (2.1 g, 25 mmol) and t-Bu2PH (3.6 g, 25 mmol) in 20 ml of THF at −78° C., using a 250 ml 3-neck flask equipped with reflux condenser and dropping funnel. The reaction mixture was stirred for 2 hours at room temperature and boiled for 20 min at reflux. After cooling to 0° C. the solution was slowly hydrolysed with 10 ml of 10% aqueous NH4Cl and oxidized by dropwise addition of 30 ml of 30% H2O2. The organic layer was separated and the aqueous solution extracted with THF (3×10 ml). The combined organic layer was dried over Na2SO4, filtered and evaporated to dryness. The obtained colourless oil was dissolved in 10 ml CHCl3 and chromatographed on silica gel (60, 230-400 mesh) using 90% CHCl3/10% MeOH as eluent. Two bands were collected. The first band was identified as starting material (epoxide). The second band was collected and evaporated to dryness. The white precipitate obtained was recrystallised from pentane. Yield 3.2 g (50%).
1H-NMR δ(C6D6): 1.1 (18H, dd, 2JPC=4.5 Hz, P—C(CH3)3); 1.15 (9H, s, C—CH3); 1.7-1.9 (2H, m, CH2); 4.0-4.1 (1H, m, CH) [ppm]. 13C-NMR δ(C6D6): 22.2 (1C, d, JPC=56.8 Hz, CH2); 25.7 (3C, CH3); 25.9 (3C, CH3); 26.3 (3C, CH3); 35.3 (1C, d, JPC=56.8 Hz, P—CMe3); 35.5 (1C, CMe3); 36.1 (1C, d, JPC=58.1 Hz, P—CMe3); 75.7 (1C, d, 2JPC=5.7 Hz, C—OH) [ppm]. 31P-NMR δ(C6D6): 77.6 ppm. MP: 98° C. Analysis Found: C, 63.22%; H, 11.72; calc. C, 64.1%; H, 11.9%.
A solution of 3 equivalents (400 mg, 1.5 mmol) of HL in 10 ml of THF was added over 10 min to a solution of one equivalent (308 mg, 0.5 mmol) of Eu[N(SiMe3)2]3 in 10 ml of THF at 0° C. and stirred overnight at RT (scheme 17). All volatile compounds were removed under reduced pressure and the residual yellow solid recrystallised from pentane to afford pale yellow catalyst 1. Yield 440 mg (94%).
1H-NMR δ(C6D6): −7.6 (3H, CH); −6.1 (27H, tBu); −4.6 (3H, CH2); −1.4 (3H, CH2); 0.4 (27H, tBu); 9.1 (27H, tBu). 31P-NMR δ(C6D6): 69.9 ppm. Analysis Found: C, 53.78%; H, 9.48%; calc. C, 53.9%; H, 9.6%.
A solution of HL (533 mg, 0.82 mmol) in 10 ml of THF was added over 10 min to a solution of one equivalent (647 mg, 2.5 mmol) of Er[N(SiMe3)2]3 in 10 ml of THF at 0° C. and stirred overnight at RT (scheme 17). All volatile compounds were removed under reduced pressure and the residual solid recrystallised from pentane to afford pale pink catalyst 2. Yield 720 mg (93%).
1H-NMR δ(C6D6): −9.15 (6×t-Bu H); 24.14 (3×t-Bu H). No other resonances observed. Analysis Found: C, 52.90%; H, 9.61%; calc. C, 53.0%; H, 9.5%.
asample purified to remove shorter chains and monomer for NMR spectroscopy
For comparison,
Using Catalysts Synthesis from MCl2/HLR
The complexes 4-6 have been tested as initiators for the polymerisation of D,L-lactide; two series of polymerizations were conducted:
The polymerisations without coinitiator were conducted in toluene at 100° C. The results obtained for series A are summarized in Table 2. Low yields were obtained in all experiments.
To compare, polymerisations using 6tBu with coinitiator were conducted in toluene at 100° C.; the results are shown in
To confirm that is not the benzylalcohol polymerise the D,L-lactide, the proligand was treated with benzylalcohol which was use in polymerization of rac-lactide, the 1H NMR spectrum show no polymerization.
Despite the fact of using a coinitiator to improve the velocity of the polymerisations, these weren't good enough. So, All reactions were carried out at 140° C., with benzyl alcohol as coinitiator to afford a melt polymerisation which the D,L-lactide is the solvent and the monomer. In the Table 3, Sn(oct)2 is the abbreviation for Sn(octanoate)2, the most widely industry catalyst, and thus a good reference.
aconversion of LA monomer (([LA]0 − [LA])/[LA]0), calculated by 1H NMR;
bmeasured by GPC, values based on polystyrene standards and corrected by multiplication by 0.47 (Mark-Houwink law);
cpolydispersity index (Mw/Mn), PDI, measured by GPC.
The polymerisations using 5 show that at 2% catalyst loading the polymerisation are slow, the molecular weights are low (below 2000 g·mol−1), and the PDIs fluctuate between 1.3-2. On the other hand, the kinetic data for Mn versus conversion show that the kinetics for the three complexes appears to be living.
The polymerisations using 4 show the best results so far; high molecular weight (15000-20000 g·mol−1) although the polydispersities are not narrow around 1.6-1.8. Also, the kinetic traces show a living nature with a linear Mn versus conversion and PDI decreases with an increasing conversion.
The polymerisation using 6 are difficult to analyse and inconsistent; generally the polymerisation rates were slow and the molecular weights low. The polymerisations using Sn(oct)2 are very slow in comparison, furthermore they are not living.
The GPC chromatogram of
The aim of this project is to polymerise a mixture of two stereocomplex PLA, poly-D-lactide and poly-L-lactide. Two separate control experiments were performed to confirm the tacticity, so it was decided that 4tBu will be use to extend the studies
In the first control experiment, the 1H NMR spectra of the stereocomplex product should look like that of poly-L-lactide, with a single CHMe resonance (if the chains are infinitely long). If the polymerisation is less selective or transterification becomes a competing reaction at higher conversions, the original stereochemical control will be lost and the proton-decoupled spectra will show the different CH environments. L-lactide was polymerised using 4tBu (
The shape of the NMR spectra samples of rac-lactide polymerised by 4tBu at 89% monomer conversion, (23b) are comparable to (23c) with the iii resonance corresponding to 35% of the combined peak areas, indicating a poor stereoselectivity of the polymerisation. It contains major additional resonances corresponding to unselective insertions.
In the second experiment, the 13C NMR spectra of the stereocomplex product should look like that of poly-L-lactide, with a single CHMe resonance (if the chains are infinitely long). If there have been transferication reactions, or unselective insertions, the control will be lost and the NMR spectra will contain resonances for the different CH environments.
Spectra samples of rac-lactide polymerised by 4tBu at 89% monomer conversion, (24b) are a shape different to (24a) confirming a poor stereoselectivity of the polymerisation. It contains major additional resonances corresponding to unselective insertions.
The GPC data and 1H NMR spectra show a linear variation between Mn and conversion and between Ln (1/(1-conv.)) and the time of polymerisation that indicates a controlled, living polymerization (
Any polymerisations were tried using a catalyst synthesise from MCl2/LiLR
Using Catalysts Synthesis from MN″n/HLR
The complex 8Ph was examined for polymerisation activity with rac-lactide (M/I=50). The polymerisations were carried out in bulk at 140° C. with coinitiator. From the polymerisation data, it is apparent than the calcium complex shows at full conversion (>95%) a narrow distribution (1.2-1.3) but a low molecular weights (around 1000-2000 g·mol−1). Some studies are carrying out with 8tBu.
The conversion versus the time of polymerisation using 8Ph is shown in
Previously in our group (Robert Blaudeck), the complex 12tBu has been tested as an initiator for the polymerization of rac-lactide (M/I=100); even at −18° C. in DCM, the polymerisation is rapid, and appears to be living in nature. The polymer weights are high (22 100 g·mol−1 at 35% of conversion and 68 600 g·mol−1 at 99%), and the polydispersities (PDI) of the polymers are narrow (1.3-1.5). Approximately half of the monomer is consumed after three minutes, during which the solution becomes extremely viscous. He also proved that with increasing M/I he obtained a decrease in the PDI (around 1.2).
Using Catalysts Synthesis from MRn/HLR
The complexes synthesis from ZnEt2 and AlMe3 yielded with so much compound that it was impossible to use the complexes 9 and 10 in polymerisation, only the complex 11 was used.
The complex 11tBu was examined for polymerisation activity with rac-lactide (M/I=50). The polymerisations were carried out in toluene at 100° C. with coinitiator. From the polymerisation data, it is apparent than the aluminium complex shows a conversion >90%, a large distribution (1.7-1.9), and a low molecular weights (around 1000-2000 g·mol−1). The conversion versus the time of polymerisation using 11tBu is shown in
All the copolymerisation between L-lactide and glycolide were carried out only with complexes 4-6: [M(HLR)2(Cl)2]
To understand the kinetic of copolymerisation between L-lactide and glycolide, different factors were changed, the metal (Mg, Zn, Sn); the ligand (tert-butyl, phenyl or octanoate); the time of polymerisation (from 10 seconds to 96 h); the feed composition (from 100% of L-lactide to 100% of glycolide); and the temperature (140° C., 160° C. or 180).
A kinetic study was carried out to find the best combination of factors. The initial conditions were: 5Ph, 140° C., 96 h, [Lac]/[Gly]=4, [Lac]/[Cat]=50.
Firstly, after 1.5 h reaction time the reaction is 64% complete and after 24 h it is 85%. Secondly, the feed composition gives the best results for a ratio 60/40 (L-lactide/glycolide). Thirdly, the conversion rate increases with increasing temperature. And the rate is also dependent on the ligand following the order tBu>Ph>octanoate. Finally, the metal affects the rate following the order Mg>Zn>Sn.
The best combination found was: 4tBu, 140° C., 24 h, [Lac]/[Gly]=1.5 [Lac]/[Cat]=50, this combination was used in microstructure studies.
At the beginning of the polymerisation, the 1H NMR spectra of the copolymer product should show just -GGGGG- pentads because the glycolide, is polymerised faster than the L-lactide; with increasing time, some -LLGGL- pentads should emerge. If the copolymerisation is less selective, no stereochemical control will be observed and the microstructure will show a different tacticity.
By applying the probability theory to the estimation of copolymer sequence distribution we expected completely random copolymer with a <<blocking >> tendency (χ<1). This is confirmed by the results of 1H NMR spectra which have shown a block tendency after 6 h (-GGGGG-) and some atactic pentades after 24 h (-LLGGL-+-LGGLL-), also confirmed by the presence of atactic tetrads after 24 h (-GGLL-) in the 13C NMR (
The GPC data (
The kinetic results are shown as a stacked plot on GPC chromatograms to demonstrate the dependence of the molecular weights with the conversion (
The GPC chromatograms confirm the results from
asolvent = dichloromethane;
bconversion of LA monomer (([LA]0 − [LA])/[LA]0).
cmeasured by GPC, values based on polystyrene standards, weight corrected by multiplication by 0.47 [Mark-Houwink equation]
dpolydispersity index (Mw/Mn), PDI, measured by GPC.
The polymers were characterized by NMR spectroscopy. The results are shown in
a) methine region of the homonuclear decoupled 1H-NMR for entry 1. Integration of the iii peak corresponds to 26.2%.
1H-NMR δ(CDCl3): 5.146, 5.161, 5.171, 5.178, 5.181, 5.185, 5.202 [ppm].
b) methine region of the homonuclear decoupled 1H-NMR for entry 2. Integration of the iii peak corresponds to 88.8%.
1H-NMR δ(CDCl3): 5.103, 5.181, 5.200 [ppm].
c) methine region of the homonuclear decoupled 1H-NMR for entry 3. Integration of the iii peak corresponds to 78.7%.
1H-NMR δ(CDCl3): 5.144, 5.160, 5.178, 5.198, 5.211, [ppm].
d) methine region of the homonuclear decoupled 1H-NMR for entry 4. Integration of the iii peak corresponds >99%.
1H-NMR δ(CDCl3): 5.151 ppm.
asolvent = dichloromethane;
bconversion of LA monomer (([LA]0-[LA])/]LA]0).
cmeasured by GPC, values based on polystyrene standards, weight corrected by multiplication by 0.47 [Mark-Houwink equation]
dpolydispersity index (Mw/Mn), PDI, measured by GPC.
1H-NMR δ(CDCl3): 5.097, 5.126, 5.139, 5.165, 5.179, [ppm].
Solution:
A teflon valve-sealed ampoule was charged with 500 mg of the monomer which was dissolved in the volume of thf required to give the ratio in the table entry, and the solution stirred at the temperature given in the table. To this was added via cannula a solution of appropriate mass of catalyst (one of 1 to 4) in 2 mls of thf (see table 6).
Melt:
The catalyst (one of 1 to 4) was ground using a pestle and mortar to a fine powder, which was mixed with the powdered monomer in a flask in the quantities 500 mg ε-caprolactone and the appropriate mass of catalyst (see table 6).
The mixture was heated in an ampoule in a sand bath to 180 centigrade. The powder melted into a viscous solution which solidified as it cooled down to RT.
Yield 99% (apparent complete conversion).
A vigorously stirred solution of 0.5 g (4.4 mmol) ε-caprolactam in 50 ml thf was treated with an solution of 5 mg ErL3 in 1 ml thf at room temperature. After 30 min the reaction mixture was quenched with 5 drops of MeOH. Removing the solvent yielded white amorphous polymer. Mn=101000 g/mol, PDI=1.4
Number | Date | Country | Kind |
---|---|---|---|
0612392.1 | Jun 2006 | GB | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB2007/050348 | 6/21/2007 | WO | 00 | 3/16/2009 |